Details of the Researcher

PHOTO

Sanjay Kumar
Section
International Center for Synchrotron Radiation Innovation Smart
Job title
Assistant Professor
Degree

  • Ph.D. (National Institute of Pharmaceutical Education and Research, Mohali, India)

  • M.S. (Pharm.) (National Institute of Pharmaceutical Education and Research, Mohali, India)

Research History 6

  • 2024/06 - Present
    Tohoku University, Sendai, Japan　Institute of Multidisciplinary Research for Advanced Materials (IMRAM)　Assistant Professor

  • 2022/05 - 2024/05
    Tohoku University, Sendai, Japan　Institute of Multidisciplinary Research for Advanced Materials (IMRAM)　JSPS Postdoc Researcher

  • 2020/11 - 2022/05
    Tohoku University, Sendai, Japan　Institute of Multidisciplinary Research for Advanced Materials (IMRAM)　Postdoc Researcher

  • 2018/11 - 2020/08
    Punjab Biotechnology Incubator (PBTI), Mohali, Punjab, India　Project Scientist

  • 2014/03 - 2014/07
    National Institute of Pharmaceutical Education and Research, Mohali, Punjab, India　Department of Natural Products　Research Fellow

  • 2013/09 - 2014/03
    SIPSAR, Gr. Noida, Uttar Pradesh Technical University, U.P. India　Assistant Professor

Show all Show first 5

Education 3

  • National Institute of Pharmaceutical Education and Research, Mohali, Punjab, India　Department of Natural Products, Ph.D.

    2014/07 - 2018/12

  • National Institute of Pharmaceutical Education and Research, Mohali, Punjab, India　Department of Natural Products, Master

    2011/07 - 2013/06

  • Sam Higginbottom University of Agriculture, Technology and Sciences, Allahabad, U.P, India　Department of Pharmaceutical Sciences, Graduation.

    2007/07 - 2011/06

Committee Memberships 3

  • International Journal of Molecular Sciences　Guest Editor

    2025 - Present

  • International Journal of Pharmacology (ISSN Print: 1811-7775 | ISSN Online: 1812-5700)　Early-Career Editorial Board Member

    2025/11 -

  • Current Molecular and Systems Pharmacology (Bentham Science Publishers; ISSN Print: 3050-8517 | ISSN Online: 3050-8525)　Associate Editorial Board Member

    2025 -

Research Interests 1

  • Organic Chemistry, Medicinal Chemistry, Chemistry of Natural Products, Isolation of Secondary Metabolites from Natural Resources, Nanoprodrugs

Awards 2

  1. Best Poster Presentation

    2018/11　NIPER, Mohali, India　Drug Discovery from Natural Products and Traditional Medicines (DDNPTM)–2018

  2. Best Poster Presentation

    2016/10　SLIET (Deemed University), Longowal, Punjab, India　National conference on Nascent Innovation in Chemical Science (NICS–2016)

Papers 29

  1. Jasmonic acid, a molecular nexus between plant defense and pharmacological activity

    Savneet Kaur, Simranjeet Singh, Daljeet Singh Dhanjal, Nadeem A. Khan, Dhriti Kapoor, Sami Rtimi, Sanjay Kumar, Praveen C Ramamurthy, Joginder Singh

    Next Research　2026/08

    DOI： 10.1016/j.nexres.2026.101938 　

    ISSN： 3050-4759

  2. Overcoming stromal barriers in pancreatic cancer via size-engineered carrier-free nano-prodrugs

    Yang, M., Suzuki, R., Koseki, Y., Kodera, S., Saijo, K., Kawakami, H., Tanita, K., Kumar, S., Oka, K., Kasai, H.

    Rsc Pharmaceutics　2026

    DOI： 10.1039/d5pm00364d 　

    ISSN： 2976-8713

  3. SN-38-indoximod conjugate: carrier free nano-prodrug for cancer therapy

    Kumar, S., Koseki, Y., Tanita, K., Shibata, A., Mizutani, A., Kasai, H.

    Therapeutic Delivery　16　(3)　2025/03/04

    DOI： 10.1080/20415990.2025.2458449 　

    ISSN： 2041-5990 2041-6008

  4. Newly acylated SN-38 homodimers: carrier-free nano-prodrugs for chemotherapy

    Kumar, S., Koseki, Y., Tanita, K., Kasai, H.

    Mendeleev Communications　35　(3)　2025

    DOI： 10.71267/mencom.7664 　

    ISSN： 0959-9436 1364-551X

  5. Photodynamic antimicrobial activity of polydiacetylene crystal nanostructure against E. coli

    Oves, M., Suzuki, R., Nakatsuji, H., Koseki, Y., Kumar, S., Oka, K., Kasai, H.

    MRS Communications　14　(6)　2024/08/08

    DOI： 10.1557/s43579-024-00622-8 　

    ISSN： 2159-6859 2159-6867

  6. A concise synthesis of methyl dihydrojasmonate and methyl (5-methylidene-4-oxocyclopent-2-en-1-yl)acetate from D-glucose

    Kumar, S., Koseki, Y., Kamishima, T., Kasai, H.

    Mendeleev Communications　34　(4)　2024/07

    DOI： 10.1016/j.mencom.2024.06.019 　

    ISSN： 0959-9436 1364-551X

  7. Carrier-free nano-prodrugs for minimally invasive cancer therapy

    Tanita, K., Koseki, Y., Kumar, S., Taemaitree, F., Mizutani, A., Nakatsuji, H., Suzuki, R., Dao, A.T.N., Fujishima, F., Tada, H., Ishida, T., Saijo, K., Ishioka, C., Kasai, H.

    Nanoscale　16　(32)　2024

    DOI： 10.1039/d4nr01763c 　

    ISSN： 2040-3364 2040-3372

  8. Recent Advances in Anti-Infective Compounds Produced by Endophytic Fungi

    Kumar, S., Pathania, I., Kamishima, T., Koseki, Y., Kasai, H., Singh, I.P.

    Fungi Bioactive Metabolites Integration of Pharmaceutical Applications　2024

    DOI： 10.1007/978-981-99-5696-8_2 　

  9. Ir‐Catalyzed Cascade Reaction Promotes the Formation of Geometrically Selective Enones from Bis‐allyl Alcohols

    Takaaki Kamishima, Yoshitaka Koseki, Hirotaka Nakatsuji, Sanjay Kumar, Keita Tanita, Hitoshi KASAI

    European Journal of Organic Chemistry　2022　(43)　2022/11/18

    Publisher: Wiley

    DOI： 10.1002/ejoc.202201002 　

    ISSN： 1434-193X 1099-0690

  10. Synthesis and In vitro Evaluation of Hydrazonomethyl-Quinolin–8–ol and Pyrazol–3–yl-Quinolin–8–ol Derivatives for Antimicrobial and Antimalarial Potential

    Sanjay Kumar, Inder Pal Singh, Purvi Shah, Siddharth K. Tripathi, Shabana I. Khan

    Medicinal Chemistry　18　(9)　949-969　2022/11

    Publisher: Bentham Science Publishers Ltd.

    DOI： 10.2174/1573406418666220303144929 　

    ISSN： 1573-4064

    More details Close

    <jats:sec> <jats:title>Background:</jats:title> <jats:p>Quinoline is a well-established nucleus displaying various biological activities. Quinolin-8-ol-containing compounds are reported for antimicrobial as well as antimalarial activity. Hydrazone- and pyrazole-containing compounds are also reported for antimicrobial activity. In this work, we have synthesized hydrazonomethyl-quinolin–8–ol and pyrazol–3–yl-quinolin–8–ol derivatives retaining quinolin-8-ol along with hydrazone/pyrazole pharmacophores.</jats:p> </jats:sec> <jats:sec> <jats:title>Objective:</jats:title> <jats:p>The objective of this work was to synthesise and evaluate in vitro hydrazonomethylquinolin– 8–ol and pyrazol–3–yl-quinolin–8–ol derivatives for antifungal, antibacterial and antimalarial activity.</jats:p> </jats:sec> <jats:sec> <jats:title>Method:</jats:title> <jats:p>Designed and synthesized hydrazonomethyl-quinolin–8–ol and pyrazol–3–yl-quinolin–8– ol derivatives were evaluated for antifungal (against Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans), antibacterial (against methicillin resistant Staphylococcus aureus (MRSA), Escherichia Coli, Pseudomonas aeruginosa and Klebsillae pneumoniae) as well as antimalarial (against Plasmodium falciparum D6 and W2 strains) activity.</jats:p> </jats:sec> <jats:sec> <jats:title>Result:</jats:title> <jats:p>Hydrazonomethyl-quinolin–8–ol (15.1-15.28) and pyrazol–3–yl-quinolin–8–ol derivatives (16.1-16.21 and 20.1-20.18) were synthesized in good to moderate yield. One-pot synthesis of pyrazol– 3–yl-quinolin–8–ol derivatives (16.1-16.21 and 20.1-20.18) was achieved. Compounds 15.3, 15.6, 15.7, 15.9-15.14, 15.16-15.19, 15.22 and 15.24 were found more potent compared to reference standard fluconazole (IC50 = 3.20 μM) against C. albicans with IC50 value less than 3 μM. Compounds 15.1, 15.2, 15.21 and 15.23 showed almost similar activity to reference standard fluconazole against C. albicans. Compounds 15.1-15.3, 15.9-15.12, 15.14-15.17, and 15.21-15.23 also showed good activity against fluconazole-resistant strain A. fumigatus with IC50 value less than 3 μM. Compounds 15.2-15.4, 15.7, 15.9, 15.17, 15.20 showed good antimalarial activity against P. falciparum D6 as well as P. falciparum W2 with IC50 values of 1.84, 1.83, 1.56, 1.49, 1.45, 1.97, 1.68 μM and 1.86, 1.40, 1.19, 1.71, 1.16, 1.34, 1.61 μM, respectively. 5-Pyrazol–3–yl-quinolin–8–ol derivatives, such as 16.3, 16.5, 16.11, 16.13, 16.19, 16.20, also showed antimalarial activity against P. falciparum D6 and W2 strains with IC50 values of 2.23, 2.16, 2.99, 2.99, 2.73, 2.12 μM and 2.91, 3.60, 4.61, 2.71, 2.31, 2.66 μM, respectively.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion:</jats:title> <jats:p>Most of the 5-hydrazonomethyl-quinolin–8–ol derivatives showed good antifungal activity against C. albicans, A. fumigatus and C. neoformans. Most of the 5-hydrazonomethylquinolin– 8–ol derivatives were found more potent than reference standard fluconazole. These derivatives may be considered as leads for further development of antifungal agents.</jats:p> </jats:sec>

  11. Arsenic‐Induced Responses in Plants

    Sanjay Kumar, Varsha Rani, Simranjeet Singh, Dhriti Kapoor, Daljeet Singh Dhanjal, Ankita Thakur, Mamta Pujari, Praveen C. Ramamurthy, Joginder Singh

    Arsenic in Plants　112-128　2022/09/09

    Publisher: Wiley

    DOI： 10.1002/9781119791461.ch6 　

  12. Pyrazole Containing Anti-HIV Agents: An Update

    Sanjay Kumar, Shiv Gupta, Varsha Rani, Priyanka Sharma

    Medicinal Chemistry　18　(8)　831-846　2022/08

    Publisher: Bentham Science Publishers Ltd.

    DOI： 10.2174/1573406418666220106163846 　

    ISSN： 1573-4064

    More details Close

    <jats:sec> <jats:title>Background:</jats:title> <jats:p>Pyrazole scaffolds have gained importance in drug discovery and development for various pharmacological activities like antiviral, antifungal, anticancer, antidepressant, antiinflammatory, antibacterial, etc. Additionally, the pyrazole moiety has shown potent anti-HIV activity as a core heterocycle or substituted heterocycles derivatives (mono, di, tri, tetra, and fused pyrazole derivatives). To assist the development of further potential anti-HIV agents containing pyrazole nucleus, here we have summarized pyrazole containing anti-HIV compounds that have been reported by researchers all over the world for the last two decades.</jats:p> </jats:sec> <jats:sec> <jats:title>Objective:</jats:title> <jats:p>Objective: The present review concentrates on an assortment of pyrazole containing compounds, particularly for potential therapeutic activity against HIV.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods:</jats:title> <jats:p>Google Scholar, Pubmed, and SciFinder were searched databases with ‘‘pyrazol’’ keywords. Further, the year of publication and keywords ‘‘Anti-HIV’’ filter was applied to obtain relevant reported literature for anti-HIV agents containing pyrazole as a core or substituted derivatives.</jats:p> </jats:sec> <jats:sec> <jats:title>Results:</jats:title> <jats:p>This review article has shown the comprehensive compilation of 220 compounds containing pyrazole nucleus and possessing anti-HIV activity by sorting approximately 40 research articles from 2001 to date. 1-(4-Benzoylpiperazin-1-yl)-2-(4-fluoro-7-(1H-pyrazol-3-yl)-1H-pyrrolo[2,3-c]pyridin- 3-yl)ethane-1,2-dione (13), 3-(3-(2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl)-4-fluoro-1H-pyrrolo[2,3- c]pyridin-7-yl)-1H-pyrazole-5-carboxamide (31), 3-(3-(2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl)-4- fluoro-1H-pyrrolo[2,3-c]pyridin-7-yl)-1H-pyrazole-5-carboxamide (88), 3-cyanophenoxypyrazole derivative (130), and 4-(4-chlorophenyl)-5-(4-methyl-5-((4-nitrophenyl)diazenyl)thiazol-2-yl)-3- phenyl-5,6-dihydro-4H-pyrazolo[4,3-d]isoxazole (178) were the most potent mono-, di-, tri-, tetrasubstituted, and fused pyrazole derivatives, respectively, which have shown potent anti-HIV activity among all the described derivatives as compared with standard anti-HIV drugs.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion:</jats:title> <jats:p>This review article provides an overview of the potential therapeutic activity of pyrazole derivatives against HIV that will be helpful for designing pyrazole containing compounds for anti-HIV activity.</jats:p> </jats:sec>

  13. Wonder or evil?: Multifaceted health hazards and health benefits of Cannabis sativa and its phytochemicals

    Shivika Datta, Praveen C. Ramamurthy, Uttpal Anand, Simranjeet Singh, Amritpal Singh, Daljeet Singh Dhanjal, Vaishali Dhaka, Sanjay Kumar, Dhriti Kapoor, Samapika Nandy, Manoj Kumar, Eapen P. Koshy, Abhijit Dey, Jarosław Proćków, Joginder Singh

    Saudi Journal of Biological Sciences　28　(12)　7290-7313　2021/12

    Publisher: Elsevier {BV}

    DOI： 10.1016/j.sjbs.2021.08.036 　

    ISSN： 1319-562X

  14. Physiological responses, tolerance, and remediation strategies in plants exposed to metalloids

    Simranjeet Singh, Vijay Kumar, Shivika Datta, Daljeet Singh Dhanjal, Satyender Singh, Sanjay Kumar, Dhriti Kapoor, Ram Prasad, Joginder Singh

    Environmental Science and Pollution Research　28　(30)　40233-40248　2021/08

    Publisher: Springer Science and Business Media {LLC}

    DOI： 10.1007/s11356-020-10293-2 　

    ISSN： 0944-1344 1614-7499

  15. Thiazole Compounds as Antiviral Agents: An Update

    Inder P. Singh, Shiv Gupta, Sanjay Kumar

    Medicinal Chemistry　16　(1)　4-23　2020/01/16

    Publisher: Bentham Science Publishers Ltd.

    DOI： 10.2174/1573406415666190614101253 　

    ISSN： 1573-4064

    More details Close

    <jats:sec> <jats:title>Background:</jats:title> <jats:p>Thiazole is a good nucleus owing to its various pharmaceutical applications. Thiazole containing compounds (thiazoles) have shown various biological activities like antioxidant, analgesic, antibacterial, anticancer, antiallergic, antihypertensive, antiinflammatory, antimalarial, antifungal and antipsychotic. The scaffold is present in more than 18 FDA approved drugs and also in more than 70 experimental drugs. Only a few reviews are available in the literature despite its great medicinal importance. During the course of time, this scaffold has been studied extensively for its antiviral activities and provided compounds with activity in the nM range. However, no focused review is available on the compilation of antiviral activities shown by this scaffold.</jats:p> </jats:sec> <jats:sec> <jats:title>Objective:</jats:title> <jats:p>In the present review, we have made an effort to compile antiviral literature of thiazoles reported from the year 2011 to till date.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods:</jats:title> <jats:p>We searched the SciFinder database (excluding patent literature) with keywords like “antiviral”, “anti-HIV” and “virus”. Further filters were applied for the year of publication and keywords thiazole, reviews etc. to find relevant literature reported on the antiviral activities of thiazoles.</jats:p> </jats:sec> <jats:sec> <jats:title> Results:</jats:title> <jats:p>Nearly, 50 research articles were selected to compile and review the antiviral literature of thiazoles reported from the year 2011 to till date. Compounds 8, 25, 40, 62, 72, 73, 91, 112, 113, 131, 137, 175, 198, 200, 201 and 213 were reported in the literature with potent antiviral activity against CVB, SARS, RSV, HCV, HRV, VZV, TMV, FMDV, DENV, YFV, influenza virus, Junin virus, HIV-1, HSV, VV and EBV, respectively.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion:</jats:title> <jats:p>There is further scope for the synthesis and evaluation of novel thiazole compounds by taking the most active compounds as lead structures. In conclusion, this review provides an overview of antiviral activities of thiazole compounds reported from the year 2011 to till date.</jats:p> </jats:sec>

  16. Pathogenesis and Antibiotic Resistance of Staphylococcus aureus

    Kumar, S., Singh, S., Kumar, V., Datta, S., Dhanjal, D.S., Sharma, P., Singh, J.

    Model Organisms for Microbial Pathogenesis Biofilm Formation and Antimicrobial Drug Discovery　99-115　2020

    Publisher: Springer Singapore

    DOI： 10.1007/978-981-15-1695-5_7 　

  17. Microbial Remediation for Wastewater Treatment

    Satyender Singh, Simranjeet Singh, Vijay Kumar, Sanjay Kumar, Daljeet Singh Dhanjal, Romina Romero, Shivika Datta, Pooja Bhadrecha, Joginder Singh

    Microorganisms for Sustainability　57-71　2020

    Publisher: Springer Singapore

    DOI： 10.1007/978-981-15-2679-4_3 　

    ISSN： 2512-1901 2512-1898

  18. Current Trends in Mycobacterium tuberculosis Pathogenesis and Drug Resistance

    Kumar, V., Singh, S., Singh, D., Datta, S., Kumar, S., Singh, S.B., Singh, J.

    Model Organisms for Microbial Pathogenesis Biofilm Formation and Antimicrobial Drug Discovery　301-322　2020

    Publisher: Springer Singapore

    DOI： 10.1007/978-981-15-1695-5_16 　

  19. Biotechnological aspects of nanoparticles driven from natural products for drug delivery system and other applications

    Singh, S., Kumar, V., Singh, S., Datta, S., Kumar, S., Bhadrecha, P., Dhanjal, D.S., Singh, J.

    Bioactive Natural Products in Drug Discovery　549-583　2020

    Publisher: Springer Singapore

    DOI： 10.1007/978-981-15-1394-7_19 　

  20. Synthesis and in–vitro anti–HIV–1 evaluation of novel pyrazolo[4,3–c]pyridin–4–one derivatives

    Sanjay Kumar, Shiv Gupta, Leila Fotooh Abadi, Shraddha Gaikwad, Dipen Desai, Kamlesh Kumar Bhutani, Smita Kulkarni, Inder Pal Singh

    European Journal of Medicinal Chemistry　183　111714-111714　2019/12

    Publisher: Elsevier {BV}

    DOI： 10.1016/j.ejmech.2019.111714 　

    ISSN： 0223-5234

  21. Design, Synthesis and In Vitro Evaluation of Novel Anti-HIV 3-Pyrazol-3- yl-Pyridin-2-One Analogs

    Sanjay Kumar, Shiv Gupta, Shraddha Gaikwad, Leila F. Abadi, Late K. K. Bhutani, Smita Kulkarni, Inder P. Singh

    Medicinal Chemistry　15　(5)　561-570　2019/07/02

    Publisher: Bentham Science Publishers Ltd.

    DOI： 10.2174/1573406414666181106125539 　

    ISSN： 1573-4064

    More details Close

    <jats:sec> <jats:title>Background:</jats:title> <jats:p>Natural products have shown potent anti-HIV activity, but some of these also possess toxicity. The pharmacophoric fragments of these natural products have scope of combination with other pharmacophoric fragment and derivatization to reduce toxicity and increase the potency. Combination of natural product fragments from different classes of anti–HIV compounds may lead to a new class of potent anti–HIV agents.</jats:p> </jats:sec> <jats:sec> <jats:title>Objective:</jats:title> <jats:p>Design, in silico prediction of drug-likeness, ADMET properties and synthesis of pyrazol– pyridones. Evaluation of the anti–HIV–1 activity of synthesized pyrazol–pyridones.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods:</jats:title> <jats:p> Pyrazol–pyridones were designed by combining reported anti–HIV pharmacophoric fragments. Designed molecules were synthesized after in silico prediction of drug-likeness and ADMET properties. Compounds were evaluated for activity against HIV–1VB59 and HIV–1UG070.</jats:p> </jats:sec> <jats:sec> <jats:title>Results:</jats:title> <jats:p>QED value of designed pyrazol–pyridones was greater than the known drug zidovudine. The designed compounds were predicted to be noncarcinogenic and nonmutagenic in nature. Seventeen novel pyrazol–pyridones were synthesized with good yield. Compound 6q and 6l showed activity with IC50 values 6.14 µM and 15.34 µM against HIV–1VB59 and 16.21 µM and 18.21 µM against HIV–1UG070, respectively.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion:</jats:title> <jats:p>Compound 6q was found to be most potent among the synthesized compounds with a therapeutic index of 54.31against HIV–1VB59. This is the first report of anti–HIV–1 activity of pyrazol–pyridone class of compounds. Although the anti–HIV–1 activity of these compounds is moderate, this study opens up a new class for exploration of chemical space for anti–HIV–1 activity.</jats:p> </jats:sec>

  22. Revealing on hydrogen sulfide and nitric oxide signals co‐ordination for plant growth under stress conditions

    Simranjeet Singh, Vijay Kumar, Dhriti Kapoor, Sanjay Kumar, Satyender Singh, Daljeet Singh Dhanjal, Shivika Datta, Jastin Samuel, Pinaki Dey, Shanquan Wang, Ram Prasad, Joginder Singh, PhD

    Physiologia Plantarum　2019/07/02

    Publisher: Wiley

    DOI： 10.1111/ppl.13002 　

    ISSN： 0031-9317 1399-3054

  23. Xanthine oxidase inhibitors from an endophytic fungus Lasiodiplodia pseudotheobromae

    Sanjay Kumar, Amol Dilip Pagar, Furkan Ahmad, Vagish Dwibedi, Aabid Wani, Prasad V. Bharatam, Manmohan Chhibber, Sanjai Saxena, Inder Pal Singh

    Bioorganic Chemistry　87　851-856　2019/06

    Publisher: Elsevier {BV}

    DOI： 10.1016/j.bioorg.2018.12.008 　

    ISSN： 0045-2068

  24. Endophytic microbes in abiotic stress management

    Singh, S., Kumar, V., Dhanjal, D.S., Sidhu, G.K., Datta, S., Kumar, S., Singh, J.

    Microbial Endophytes Prospects for Sustainable Agriculture　91-123　2019

    Publisher: Elsevier

    DOI： 10.1016/B978-0-12-818734-0.00005-X 　

  25. Endophytic bacteria in xenobiotic degradation

    Datta, S., Singh, S., Kumar, V., Dhanjal, D.S., Sidhu, G.K., Amin, D.S., Kumar, S., Singh, J., Singh, J.

    Microbial Endophytes Prospects for Sustainable Agriculture　125-156　2019

    Publisher: Elsevier

    DOI： 10.1016/B978-0-12-818734-0.00006-1 　

  26. Synthesis of C-2 and C-3 substituted quinolines and their evaluation as anti-HIV-1 agents

    Purvi Shah, Dharav Naik, Nisha Jariwala, Deepali Bhadane, Sanjay Kumar, Smita Kulkarni, Kamlesh Kumar Bhutani, Inder Pal Singh

    Bioorganic Chemistry　80　591-601　2018/10

    Publisher: Elsevier {BV}

    DOI： 10.1016/j.bioorg.2018.07.016 　

    ISSN： 0045-2068

  27. In Silico Prioritization, Synthesis and In Vitro Evaluation of Tembamide Analogs for Anti-HIV Activity

    Shiv Gupta, Sanjay Kumar, Nisha Jariwala, Deepali Bhadane, Kamlesh Kumar Bhutani, Smita Kulkarni, Inder Pal Singh

    Letters in Drug Design &amp; Discovery　14　(12)　2017/10/31

    Publisher: Bentham Science Publishers Ltd.

    DOI： 10.2174/1570180814666170419115526 　

    ISSN： 1570-1808

  28. Naphthyridines with Antiviral Activity - A Review

    Inder P. Singh, Sanjay Kumar, Shiv Gupta

    Medicinal Chemistry　13　(5)　2017/07/11

    Publisher: Bentham Science Publishers Ltd.

    DOI： 10.2174/1573406412666161228112127 　

    ISSN： 1573-4064

  29. Quantification of Acteoside in Clerodendrum colebrookianum Walp. by qNMR, HPLC and HPTLC

    Kumar Sanjay

    Trends in Carbohydrate Research　2016/10/01

Show all ︎Show first 5

Presentations 3

  1. Carrier free nano-prodrugs for cancer therapy Invited

    Sanjay Kumar

    international conference on Pharma and Allied Sciences in the Age of AI: Innovations and IPR Strategies (PASAI - 2026)

  2. Endophytic fungus (Lasiodiplodia pseudotheobromae): Source of xanthine oxidase inhibitors

    Expert talk in ISFCP Dialogue Series-2023, ISF College of Pharmacy, Moga, Punjab, India

  3. Design and Synthesis of Pyrazole-based Anti-HIV compounds

    4th International Symposium towards Future of Advanced Research in Shizuoka University 2018, Hamamatsu Campus of Shizuoka University